131 related articles for article (PubMed ID: 6414691)
1. High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
Klein HO; Wickramanayake PD; Coerper C; Christian E; Pohl J; Brock N
Cancer Treat Rev; 1983 Sep; 10 Suppl A():167-73. PubMed ID: 6414691
[No Abstract] [Full Text] [Related]
2. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
Scheulen ME; Niederle N; Bremer K; Schütte J; Seeber S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():93-101. PubMed ID: 6414700
[TBL] [Abstract][Full Text] [Related]
3. Infusion of ifosfamide plus mesna.
Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
[No Abstract] [Full Text] [Related]
4. Infusion of ifosphamide plus mesna.
Shaw IC; Rose JW
Lancet; 1984 Jun; 1(8390):1353-4. PubMed ID: 6145051
[No Abstract] [Full Text] [Related]
5. High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
Stuart-Harris R; Harper PG; Kaye SB; Wiltshaw E
Cancer Treat Rev; 1983 Sep; 10 Suppl A():163-4. PubMed ID: 6414689
[No Abstract] [Full Text] [Related]
6. Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
Klein HO; Wickramanayake PD; Christian E; Coerper C; Graf L
Cancer Treat Rev; 1983 Sep; 10 Suppl A():83-92. PubMed ID: 6414699
[No Abstract] [Full Text] [Related]
7. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
Stuart-Harris RC; Harper PG; Parsons CA; Kaye SB; Mooney CA; Gowing NF; Wiltshaw E
Cancer Chemother Pharmacol; 1983; 11(2):69-72. PubMed ID: 6414732
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Matthiessen W; Stempinski E; Göbel D; Thalmann U
Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
[No Abstract] [Full Text] [Related]
9. High-dose ifosfamide with mesna uroprotection: a phase I study.
Elias AD; Eder JP; Shea T; Begg CB; Frei E; Antman KH
J Clin Oncol; 1990 Jan; 8(1):170-8. PubMed ID: 2104923
[TBL] [Abstract][Full Text] [Related]
10. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Sanchiz F; Milla A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S91-2. PubMed ID: 2112057
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
Focan C; Boossy J; Focan-Henrard D; Reginster M; Claessens JJ
Cancer Chemother Pharmacol; 1989; 23(3):192-3. PubMed ID: 2493996
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide/mesa and encephalopathy.
Cantwell BM; Harris AL
Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
[No Abstract] [Full Text] [Related]
13. Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
Hilgard P; Burkert H
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1451-2. PubMed ID: 6437825
[No Abstract] [Full Text] [Related]
14. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Cantwell BM; Harris AL; Bozzino JM
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S29. PubMed ID: 3028660
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
Klein HO; Dias Wickramanayake P; Coerper C; Christian E
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S19. PubMed ID: 3102091
[No Abstract] [Full Text] [Related]
16. Mesna: continuous or bolus infusion?
Willemse PH; de Vries EG
J Clin Oncol; 1989 Jun; 7(6):817-9. PubMed ID: 2497231
[No Abstract] [Full Text] [Related]
17. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
Pratt CB; Douglass EC; Etcubanas E; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):51-5. PubMed ID: 2495567
[TBL] [Abstract][Full Text] [Related]
18. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258
[TBL] [Abstract][Full Text] [Related]
19. Clinical overview of mesna.
Burkert H
Cancer Treat Rev; 1983 Sep; 10 Suppl A():175-81. PubMed ID: 6414692
[TBL] [Abstract][Full Text] [Related]
20. Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
Cancer Treat Rev; 1983 Sep; 10 Suppl A():1-192. PubMed ID: 6414687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
